GB Sciences, Inc. Overview
Company Headquarter: Nevada, US
Founded: 2001
Workforce: ~50
Company Working: GB Sciences, Inc. is a phytomedicine research and biopharmaceutical drug development company that converts the cannabis plant into medicines, therapies, and treatment-based drugs. The company’s novel drug development pipeline is built through collaborations with top university researchers and industry leaders in novel delivery and manufacturing processes. It operates numerous subsidiaries such as Growblox Life Sciences LLC (US), Growblox Sciences Puerto Rico LLC (US), GB Sciences Las Vegas, LLC (US), and GB Sciences Nevada, LLC (US).
Strategy
GB Sciences, Inc. is involved in the research & development of medicinal plants to improve its product line. It is focusing on launching unique solutions in the market. It is investing in R&D activities. Its products will help spur future growth in the region. Its strategy includes the proprietary PhAROS drug discovery platform and high-throughput screening of cell and animal models of specific disease processes in order to create rationally designed minimally essential mixtures.



